Cellular and molecular therapeutic modalities for arterial obstructive syndromes

Pharmacology and Therapeutics

Volumn 109, Issue 1-2, 2006, Pages 263-273

  Staudacher, Dawid L ^a   Preis, Meir ^a   Lewis, Basil S ^a   Grossman, P Michael ^b   Flugelman, Moshe Y ^a  

^a CARMEL MEDICAL CENTER   (Israel)

^b UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

Arterial obstructive syndromes; Gene therapy; Molecular therapy; Stem cells

Indexed keywords

ADENOVIRUS VECTOR; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PLASMID DNA; RECOMBINANT FIBROBLAST GROWTH FACTOR; RECOMBINANT FIBROBLAST GROWTH FACTOR 2; RECOMBINANT FIBROBLAST GROWTH FACTOR 4; RECOMBINANT VASCULAR ENDOTHELIAL GROWTH FACTOR 121; RECOMBINANT VASCULAR ENDOTHELIAL GROWTH FACTOR 165; RECOMBINANT VASCULOTROPIN; RETROVIRUS VECTOR; UNCLASSIFIED DRUG;

ANGINA PECTORIS; ANGIOGENESIS; ARTERY DISEASE; BONE MARROW CELL; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COMBINED IMMUNODEFICIENCY; CORONARY ARTERY DISEASE; DEATH; DRUG EFFECT; DRUG HALF LIFE; HEART INFARCTION; HEART MUSCLE; HUMAN; IMMUNITY; INFLAMMATION; INTERMITTENT CLAUDICATION; LEUKEMIA; MOLECULAR MECHANICS; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; RESTENOSIS; REVIEW; SMOOTH MUSCLE FIBER; STEM CELL; TREATMENT FAILURE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; ARTERIAL OCCLUSIVE DISEASES; COLONY-STIMULATING FACTORS; FIBROBLAST GROWTH FACTORS; GENE THERAPY; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELL TRANSPLANTATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 28444452941     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2005.08.005     Document Type: Review

References (86)

1. AHA International Cardiovascular Disease Statistics 2005 American Heart Association
2. N. Al Attar, A.B. Razak, and M. Scorsin Cellular transplantation: new horizons in the surgical management of heart failure J R Coll Surg Edinb 47 2002 749 752
3. T. Asahara, and A. Kawamoto Endothelial progenitor cells for postnatal vasculogenesis Am J Physiol Cell Physiol 287 2004 C572 C579
4. T. Asahara, T. Murohara, A. Sullivan, M. Silver, R. Van Der Zee, and T. Li Isolation of putative progenitor endothelial cells for angiogenesis Science 275 1997 964 967
5. T. Asahara, H. Masuda, T. Takahashi, C. Kalka, C. Pastore, and M. Silver Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization Circ Res 85 1999 221 228
6. D.O. Bates, N.J. Hillman, B. Williams, C.R. Neal, and T.M. Pocock Regulation of microvascular permeability by vascular endothelial growth factors J Anat 200 2002 581 597
7. A.P. Beltrami, K. Urbanek, J. Kajstura, S.M. Yan, N. Finato, and R. Bussani Evidence that human cardiac myocytes divide after myocardial infarction N Engl J Med 344 2001 1750 1757
8. B. Berse, L.F. Brown, L. Van De Water, H.F. Dvorak, and D.R. Senger Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors Mol Biol Cell 3 1992 211 220
9. C.M. Bloor, F.C. White, and T.M. Sanders Effects of exercise on collateral development in myocardial ischemia in pigs J Appl Physiol 56 1984 656 665
10. M.B. Britten, N.D. Abolmaali, B. Assmus, R. Lehmann, J. Honold, and J. Schmitt Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging Circulation 108 2003 2212 2218
11. S.L. Brody, and R.G. Crystal Adenovirus-mediated in vivo gene transfer Ann N Y Acad Sci 716 1994 90 101
12. I. Buschmann, and W. Schaper The pathophysiology of the collateral circulation (arteriogenesis) J Pathol 190 2000 338 442
13. I. Buschmann, M. Heil, M. Jost, and W. Schaper Influence of inflammatory cytokines on arteriogenesis Microcirculation 10 2003 371 379
14. P. Carmeliet Mechanisms of angiogenesis and arteriogenesis Nat Med 6 2000 389 395
15. H. Chen, A. Chedotal, Z. He, C.S. Goodman, and M. Tessier-Lavigne Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III Neuron 19 1997 547 559
16. S.L. Chen, W.W. Fang, F. Ye, Y.H. Liu, J. Qian, and S.J. Shan Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction Am J Cardiol 94 2004 92 95
17. J.A. Fallavollita, U. Valeti, S. Oza, and J.M. Canty Jr. Spatial heterogeneity of endocardial voltage amplitude in viable, chronically dysfunctional myocardium Basic Res Cardiol 99 2004 212 222
18. F. Fernandez-Aviles, J.A. San Roman, J. Garcia-Frade, M.E. Fernandez, M.J. Penarrubia, and L. De La Fuente Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction Circ Res 95 2004 742 748
19. N. Ferrara, K. Houck, L. Jakeman, and D.W. Leung Molecular and biological properties of the vascular endothelial growth factor family of proteins Endocr Rev 13 1992 18 32
20. N. Ferrara, H.P. Gerber, and J. Lecouter The biology of VEGF and its receptors Nat Med 9 2003 669 676
21. L. Fischer, M. Preis, A. Weisz, B. Koren, B. Lewis, and M. Flugelman Viral vectors for vascular gene therapy Exp Clin 2002 106 112
22. M.Y. Flugelman, and B.S. Lewis The promise of myocardial repair-towards a better understanding Eur Heart J 25 2004 1483 1485
23. J. Folkman Tumor angiogenesis: therapeutic implications N Engl J Med 285 1971 1182 1186
24. S.B. Freedman, and J.M. Isner Therapeutic angiogenesis for coronary artery disease Ann Intern Med 136 2002 54 71
25. S. Fuchs, R. Baffour, Y.F. Zhou, M. Shou, A. Pierre, and F.O. Tio Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia J Am Coll Cardiol 37 2001 1726 1732
26. P. Gerwins, E. Skoldenberg, and L. Claesson-Welsh Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis Crit Rev Oncol Hematol 34 2000 185 194
27. C.L. Grines, M.W. Watkins, J.J. Mahmarian, A.E. Iskandrian, J.J. Rade, and P. Marrott A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina J Am Coll Cardiol 42 2003 1339 1347
28. M. Gruchala, S. Bhardwaj, K. Pajusola, H. Roy, T.T. Rissanen, and I. Kokina Gene transfer into rabbit arteries with adeno-associated virus and adenovirus vectors J Gene Med 6 2004 545 554
29. M. Hedman, J. Hartikainen, M. Syvanne, J. Stjernvall, A. Hedman, and A. Kivela Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT) Circulation 107 2003 2677 2683
30. T. Henry Gene therapy did not increase exercise duration at interim analysis Transcatheter Cardiovascular Therapeutics (TCT) Meeting 2004 2004
31. T.D. Henry, B.H. Annex, G.R. Mckendall, M.A. Azrin, J.J. Lopez, and F.J. Giordano The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis Circulation 107 2003 1359 1365
32. I.E. Hoefer, N. Van Royen, I.R. Buschmann, J.J. Piek, and W. Schaper Time course of arteriogenesis following femoral artery occlusion in the rabbit Cardiovasc Res 49 2001 609 617
33. D.A. Ingram, L.E. Mead, D.B. Moore, W. Woodard, A. Fenoglio, and M.C. Yoder Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells Blood 105 2005 2783 2786
34. C. Kalka, H. Masuda, T. Takahashi, W.M. Kalka-Moll, M. Silver, and M. Kearney Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization Proc Natl Acad Sci U S A 97 2000 3422 3427
35. H.J. Kang, H.S. Kim, S.Y. Zhang, K.W. Park, H.J. Cho, and B.K. Koo Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial Lancet 363 2004 751 756
36. J. Kastrup, E. Jørgensena, V. Drvotab, L. Thuesend, H.E. Bøtkerd, and M. Gyöngyösie Intramyocardial injection of genes with a novel percutaneous technique: initial safety data of the Euroinject One Study Heart Drug 1 2001 299 304 10.1159/000048979
37. J. Kastrup, E. Jørgensena, A. Rückb, and E. Al Gene therapy with phVEGF-A165 in severe ischemic heart disease: the Euroinject One Trial-late breaking clinical trial American College of Cardiology 52nd Annual Scientific Session, Chicago, IL 2003
38. J. Kastrup, E. Jorgensen, A. Ruck, K. Tagil, D. Glogar, and W. Ruzyllo Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris. A randomized double-blind placebo-controlled study: the Euroinject One trial J Am Coll Cardiol 45 2005 982 988
39. T. Kinnaird, E. Stabile, S.E. Epstein, and S. Fuchs Current perspectives in therapeutic myocardial angiogenesis J Interv Cardiol 16 2003 289 297
40. A.A. Kocher, M.D. Schuster, M.J. Szabolcs, S. Takuma, D. Burkhoff, and J. Wang Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function Nat Med 7 2001 430 436
41. A.L. Kolodkin, D.V. Levengood, E.G. Rowe, Y.T. Tai, R.J. Giger, and D.D. Ginty Neuropilin is a semaphorin III receptor Cell 90 1997 753 762
42. F. Kuethe, B.M. Richartz, H.G. Sayer, C. Kasper, G.S. Werner, and K. Hoffken Lack of regeneration of myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans with large anterior myocardial infarctions Int J Cardiol 97 2004 123 127
43. R.J. Laham, M. Simons, and F. Sellke Gene transfer for angiogenesis in coronary artery disease Annu Rev Med 52 2001 485 502
44. D.F. Lazarous, M. Shou, M. Scheinowitz, E. Hodge, V. Thirumurti, and A.N. Kitsiou Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury Circulation 94 1996 1074 1082
45. R.J. Lederman, F.O. Mendelsohn, R.D. Anderson, J.F. Saucedo, A.N. Tenaglia, and J.B. Hermiller Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial Lancet 359 2002 2053 2058
46. S. Lehrman Virus treatment questioned after gene therapy death Nature 401 1999 517 518
47. H.H. Lipowsky, S. Kovalcheck, and B.W. Zweifach The distribution of blood rheological parameters in the microvasculature of cat mesentery Circ Res 43 1978 738 749
48. D.W. Losordo, and S. Dimmeler Therapeutic angiogenesis and vasculogenesis for ischemic disease: Part I. Angiogenic cytokines Circulation 109 2004 2487 2491
49. E. Marshall Gene therapy. Second child in French trial is found to have leukemia Science 299 2003 320
50. J.Y. Min, Y. Yang, K.L. Converso, L. Liu, Q. Huang, and J.P. Morgan Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats J Appl Physiol 92 2002 288 296
51. E.R. Mohler III, S. Rajagopalan, J.W. Olin, J.D. Trachtenberg, H. Rasmussen, and R. Pak Adenoviral-mediated gene transfer of vascular endothelial growth factor in critical limb ischemia: safety results from a phase I trial Vasc Med 8 2003 9 13
52. C.E. Murry, R.W. Wiseman, S.M. Schwartz, and S.D. Hauschka Skeletal myoblast transplantation for repair of myocardial necrosis J Clin Invest 98 1996 2512 2523
53. D. Orlic, J. Kajstura, S. Chimenti, D.M. Bodine, A. Leri, and P. Anversa Bone marrow stem cells regenerate infarcted myocardium Pediatr Transplant 7 Suppl. 3 2003 86 88
54. W.F. Penny, and H.K. Hammond Clinical use of intracoronary gene transfer of fibroblast growth factor for coronary artery disease Curr Gene Ther 4 2004 225 230
55. S. Rajagopalan, E. Mohler III, R.J. Lederman, J. Saucedo, F.O. Mendelsohn, and J. Olin Regional angiogenesis with vascular endothelial growth factor (VEGF) in peripheral arterial disease: design of the RAVE trial Am Heart J 145 2003 1114 1118
56. S. Rajagopalan, E.R. Mohler III, R.J. Lederman, F.O. Mendelsohn, J.F. Saucedo, and C.K. Goldman Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication Circulation 108 2003 1933 1938
57. H.S. Rasmussen, C.S. Rasmussen, and J. Macko VEGF gene therapy for coronary artery disease and peripheral vascular disease Cardiovasc Radiat Med 3 2002 114 117
58. T. Reffelmann, and R.A. Kloner Cellular cardiomyoplasty-cardiomyocytes, skeletal myoblasts, or stem cells for regenerating myocardium and treatment of heart failure? Cardiovasc Res 58 2003 358 368
59. W. Risau, and I. Flamme Vasculogenesis Annu Rev Cell Dev Biol 11 1995 73 91
60. C.J. Robinson, and S.E. Stringer The splice variants of vascular endothelial growth factor (VEGF) and their receptors J Cell Sci 114 2001 853 865
61. V. Schachinger, B. Assmus, M.B. Britten, J. Honold, R. Lehmann, and C. Teupe Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial J Am Coll Cardiol 44 2004 1690 1699
62. W. Schaper, and I. Buschmann Arteriogenesis, the good and bad of it Cardiovasc Res 43 1999 835 837
63. W. Schaper, and W.D. Ito Molecular mechanisms of coronary collateral vessel growth Circ Res 79 1996 911 919
64. C. Schmidt-Lucke, L. Rossig, S. Fichtlscherer, M. Vasa, M. Britten, and U. Kamper Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair Circulation 111 2005 2981 2987
65. D. Scholz, W.J. Cai, and W. Schaper Arteriogenesis, a new concept of vascular adaptation in occlusive disease Angiogenesis 4 2001 247 257
66. C. Seiler, T. Pohl, K. Wustmann, D. Hutter, P.A. Nicolet, and S. Windecker Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study Circulation 104 2001 2012 2017
67. M. Simons Angiogenesis: where do we stand now? Circulation 111 2005 1556 1566
68. M. Simons, B.H. Annex, R.J. Laham, N. Kleiman, T. Henry, and H. Dauerman Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial Circulation 105 2002 788 793
69. D.J. Stewart Late-breaking clinical trial abstracts-a phase 2, randomized, multicenter, 26-week study to assess the efficacy and safety of BIOBYPASS (AdGVVEGF121.10) delivered through minimally invasive surgery versus maximum medical treatment in patients with severe angina, advanced coronary artery disease, and no options for revascularization Circulation 106 2002 2986-a
70. E. Storkebaum, D. Lambrechts, and P. Carmeliet VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection BioEssays 26 2004 943 954
71. B.E. Strauer, M. Brehm, T. Zeus, M. Kostering, A. Hernandez, and R.V. Sorg Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans Circulation 106 2002 1913 1918
72. Q. Sun, R.R. Chen, Y. Shen, D.J. Mooney, S. Rajagopalan, and P.M. Grossman Sustained vascular endothelial growth factor delivery enhances angiogenesis and perfusion in ischemic hind limb Pharm Res 22 2005 1110 1116
73. T. Takahashi, C. Kalka, H. Masuda, D. Chen, M. Silver, and M. Kearney Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization Nat Med 5 1999 434 438
74. S. Takeshita, L.P. Zheng, E. Brogi, M. Kearney, L.Q. Pu, and S. Bunting Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model J Clin Invest 93 1994 662 670
75. T. Tammela, B. Enholm, K. Alitalo, and K. Paavonen The biology of vascular endothelial growth factors Cardiovasc Res 65 2005 550 563
76. K. Urbanek, D. Torella, F. Sheikh, A. De Angelis, D. Nurzynska, and F. Silvestri Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure Proc Natl Acad Sci U S A 2005 8692 8697
77. E. Van Belle, L. Maillard, F.O. Tio, and J.M. Isner Accelerated endothelialization by local delivery of recombinant human vascular endothelial growth factor reduces in-stent intimal formation Biochem Biophys Res Commun 235 1997 311 316
78. M. Vanderheyden, S. Mansour, and J. Bartunek Accelerated atherosclerosis following intracoronary haematopoietic stem cell administration Heart 91 2005 448
79. N. Van Royen, J.J. Piek, I. Buschmann, I. Hoefer, M. Voskuil, and W. Schaper Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease Cardiovasc Res 49 2001 543 553
80. J.S. Wang, D. Shum-Tim, E. Chedrawy, and R.C. Chiu The coronary delivery of marrow stromal cells for myocardial regeneration: pathophysiologic and therapeutic implications J Thorac Cardiovasc Surg 122 2001 699 705
81. WHO The World Health Report 2004 2004 World Health Organization
82. K.C. Wollert, G.P. Meyer, J. Lotz, S. Ringes-Lichtenberg, P. Lippolt, and C. Breidenbach Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial Lancet 364 2004 141 148
83. K. Yamamoto, T. Sokabe, T. Watabe, K. Miyazono, J.K. Yamashita, and S. Obi Fluid shear stress induces differentiation of Flk-1-positive embryonic stem cells into vascular endothelial cells in vitro Am J Physiol Heart Circ Physiol 288 2005 H1915 H1924
84. S. Yla-Herttuala, and K. Alitalo Gene transfer as a tool to induce therapeutic vascular growth Nat Med 9 2003 694 701
85. S. Yla-Herttuala, and J.F. Martin Cardiovascular gene therapy Lancet 355 2000 213 222
86. M.S. Zumberg, H.L. Leather, C. Nejame, C. Meyer, and J.R. Wingard GM-CSF versus G-CSF: engraftment characteristics, resource utilization, and cost following autologous PBSC transplantation Cytotherapy 4 2002 531 538